Item 8.01 Other Events

On September 14, 2020, the United States District Court for the District of New Jersey (the "Court") entered an order preliminarily approving a derivative settlement and providing for notice of the settlement to stockholders of American Renal Associates Holdings, Inc. (the "Company") in the matter captioned Johnson v. Carlucci, et al., Civil Action No. 2:19-cv-15812-MAH (D.N.J.). The proposed settlement is subject to final approval by the Court. A settlement hearing is scheduled for December 14, 2020. As required by the order, the Notice of Proposed Settlement of Derivative Action (the "Notice") is attached to this Current Report on Form 8-K as Exhibit 99.1. The Notice and the Stipulation and Agreement of Settlement, dated July 2, 2020 are also available on the Company's website at http://ir.americanrenal.com/. Other information contained in or accessible through the Company's website does not constitute part of, and is not incorporated into, this Form 8-K.

Forward-Looking Statements

Certain statements in this Form 8-K are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the proposed settlement of the derivative action. For such statements, the Company claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from the Company's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the settlement may not receive requisite approval, may not have the expected impact, including resolving the derivative action, or may require more activity or expense than expected. Additional factors that could cause actual results to differ materially from those stated or implied by the Company's forward-looking statements are disclosed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the time of the filing of this Form 8-K. The Company disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.

Exhibit              Description
  99.1                 Notice of Proposed Settlement of Derivative Action
104                  Cover Page Interactive Data File (embedded within the Inline XBRL document)


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses